S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
Stock market today: World shares shrug off Wall St blues as investors eye corporate earnings
Japan's anti-monopoly body orders Google to fix ad search limits affecting Yahoo
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
Stock market today: World shares shrug off Wall St blues as investors eye corporate earnings
Japan's anti-monopoly body orders Google to fix ad search limits affecting Yahoo
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
Stock market today: World shares shrug off Wall St blues as investors eye corporate earnings
Japan's anti-monopoly body orders Google to fix ad search limits affecting Yahoo
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
Stock market today: World shares shrug off Wall St blues as investors eye corporate earnings
Japan's anti-monopoly body orders Google to fix ad search limits affecting Yahoo

Replimune Group (REPL) Earnings Date, Estimates & Call Transcripts

$6.45
-0.52 (-7.46%)
(As of 04/19/2024 08:51 PM ET)

Earnings Summary

Upcoming
Earnings Date
May. 16Estimated
Actual EPS
(Feb. 8)
-$0.77 Beat By $0.12
Consensus EPS
(Feb. 8)
-$0.89
Skip Charts & View Estimated and Actual Earnings Data

REPL Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

REPL Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Replimune Group Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20242($0.87)($0.80)($0.84)
Q2 20242($0.96)($0.80)($0.88)
Q3 20242($0.90)($0.85)($0.88)
Q4 20243($1.01)($0.74)($0.91)
FY 20249($3.74)($3.19)($3.50)
Q1 20251($0.77)($0.77)($0.77)
Q2 20252($0.79)($0.77)($0.78)
Q3 20252($0.82)($0.71)($0.77)
Q4 20252($0.85)($0.69)($0.77)
FY 20257($3.23)($2.94)($3.09)

REPL Earnings Date and Information

Replimune Group last announced its quarterly earnings data on February 8th, 2024. The reported ($0.77) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.89) by $0.12. Replimune Group has generated ($3.16) earnings per share over the last year (($3.16) diluted earnings per share). Earnings for Replimune Group are expected to grow in the coming year, from ($3.28) to ($2.99) per share. Replimune Group has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 16th, 2024 based off prior year's report dates.

Replimune Group Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/16/2024
Estimated)
------- 
2/8/2024Q3 2024($0.89)($0.77)+$0.12($0.77)--  
11/7/2023Q2 2024($0.80)($0.90)($0.10)($0.90)--    
8/3/2023Q1 2024($0.80)($0.75)+$0.05($0.75)--  
5/18/2023Q4 2023($0.66)($0.74)($0.08)($0.74)--
2/9/2023Q3 2023($0.77)($0.69)+$0.08($0.69)--
11/3/2022Q2 2023($0.78)($0.79)($0.01)($0.79)--
8/4/2022Q1 2023($0.63)($0.78)($0.15)($0.78)--
5/19/2022Q4 2022($0.60)($0.60)-($0.60)--
2/3/2022Q3 2022($0.58)($0.57)+$0.01($0.57)--
11/4/2021Q3 2021($0.51)($0.56)($0.05)($0.56)--
8/6/2021Q2 2021($0.44)($0.53)($0.09)($0.53)--
5/20/2021Q1 2021($0.41)($0.41)-($0.41)--

Replimune Group Earnings - Frequently Asked Questions

When is Replimune Group's earnings date?

Replimune Group has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 16th, 2024 based off last year's report dates. Learn more on REPL's earnings history.

Did Replimune Group beat their earnings estimates last quarter?

In the previous quarter, Replimune Group (NASDAQ:REPL) reported ($0.77) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.89) by $0.12. Learn more on analysts' earnings estimate vs. REPL's actual earnings.

How can I view Replimune Group's earnings report?

Replimune Group's earnings report can be found in their filing with the SEC. View SEC filing

How much profit does Replimune Group generate each year?

Replimune Group (NASDAQ:REPL) has a recorded net income of -$174.28 million. REPL has generated -$3.16 earnings per share over the last four quarters.

What is Replimune Group's EPS forecast for next year?

Replimune Group's earnings are expected to grow from ($3.28) per share to ($2.99) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:REPL) was last updated on 4/22/2024 by MarketBeat.com Staff

From Our Partners